Written question asked by Bob Blackman (Conservative) on Friday, 5 June 2026, in the House of Commons. It was due for an answer on Tuesday, 9 June 2026. It was answered by Sharon Hodgson (Labour) on Thursday, 11 June 2026 on behalf of the Department of Health and Social Care.
Cystic Fibrosis
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of co-morbidities such as liver disease which affects one in five people with cystic fibrosis as we mark cystic fibrosis awareness week from 8-14 June.
- Answer
-
National Institute for Health and Care Excellence (NICE) guidelines recommend that patients and/or the families of people with cystic fibrosis are provided with the relevant information and the opportunity for discussion with clinicians on topics that include their diagnosis, monitoring of their condition, management options, and existing or possible complications that could relate to comorbidities like liver disease. NICE guidelines are available at the following link:
Secondary information
- Type
- Written question
- Reference
- 7125
- Session
- 2026-27
- Subjects
- Cystic fibrosis Liver diseases
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-06-11 10:15:50 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/7125
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/7125
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/7125